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We have investigated the chemokine receptor expression and migratory behavior of a new subset of nickel-specific skin-homing
regulatory CD4 T cells (ThIL-10) releasing high levels of IL-10, low IFN- , and undetectable IL-4. These cells inhibit in a
IL-10-dependent manner the capacity of dendritic cells to activate nickel-specific Tc1 and Th1 lymphocytes. RNase protection
assay and FACS analysis revealed the expression of a vast repertoire of chemokine receptors on resting ThIL-10, including the
Th1-associated CXCR3 and CCR5, and the Th2-associated CCR3, CCR4, and CCR8, the latter at higher levels compared with
Th2 cells. The most active chemokines for resting ThIL-10, in terms of calcium mobilization and in vitro migration, were in order
of potency: CCL2 (monocyte chemoattractant protein-1, CCR2 ligand), CCL4 (macrophage-inflammatory protein-1 , CCR5
ligand), CCL3 (macrophage-inflammatory protein-1 , CCR1/5 ligand), CCL17 (thymus and activation-regulated chemokine,
CCR4 ligand), CCL1 (I-309, CCR8 ligand), CXCL12 (stromal-derived factor-1, CXCR4), and CCL11 (eotaxin, CCR3 ligand).
Consistent with receptor expression down-regulation, activated ThIL-10 exhibited a reduced or absent response to most chemo-
kines, but retained a significant migratory capacity to I-309, monocyte chemoattractant protein-1, and thymus and activation-
regulated chemokine. I-309, which was ineffective on Th1 lymphocytes, attracted more efficiently ThIL-10 than Th2 cells. I-309 and
CCR8 mRNAs were not detected in unaffected skin and were up-regulated at the skin site of nickel-allergic reaction, with an
earlier expression kinetics compared with IL-10 and IL-4. Results indicate that skin-homing regulatory ThIL-10 lymphocytes
coexpress functional Th1- and Th2-associated chemokine receptors, and that CCR8/I-309-driven recruitment of both resting and
activated ThIL-10 cells may be critically involved in the regulation of Th1-mediated skin allergic disorders.             
                             
C ompelling evidence indicates the existence of specializedCD4 T lymphocytes with the potential to regulate avariety of immune responses through the release of sup-
pressive cytokines (1–3). In particular, IL-10-producing CD4 T
cells appear to be profoundly involved in the modulation of auto-
immune diseases as well as in the induction of transplantation
tolerance (4– 6). Allergic diseases are the consequence of exag-
gerated immune responses against innocuous non-self Ags. Aller-
gic contact dermatitis to nickel is a prototypic type 1-mediated
immune response and depends upon the recruitment of Th1 and
Tc1 lymphocytes at the skin site of nickel application in sensitized
individuals (7–10). We have recently found that the skin and pe-
ripheral blood of nickel-allergic patients as well as the blood of
healthy donors bear a substantial proportion of nickel-specific
CD4 T clones which produce high amounts of IL-10, low or
undetectable IFN- , and no IL-4 (11). These nickel-specific IL-
10-producing Th cells (ThIL-10)3 express the skin-homing receptor,
cutaneous lymphocyte-associated Ag (CLA), and block in a IL-
10-dependent manner the differentiation and maturation of den-
dritic cells, thus impairing their capacity to activate nickel-specific
Tc1 and Th1 effector lymphocytes (12).
Many recent findings indicate that chemokine receptors are dif-
ferentially expressed on memory T cells depending on their po-
larization (13–18), with Th1 lymphocytes expressing CCR5 and
CXCR3, and Th2 lymphocytes CCR3, CCR4, and CCR8. As a
consequence, selective chemotactic stimuli contribute to the dif-
ferential positioning of Th1 and Th2 cells within tissues (19–21).
Here, we analyzed the chemokine receptor profile and migratory
properties of skin-homing nickel-specific ThIL-10 lymphocytes.
Our results demonstrate that resting ThIL-10 cells coexpress func-
tional Th1 and Th2 chemokine receptors and migrate in response
to a variety of chemokines. Upon activation, ThIL-10 cells are at-
tracted exclusively by CCL1 (I-309), CCL2 (monocyte chemoat-
tractant protein-1, MCP-1), CCL17 (thymus and activation-regu-
lated chemokine, TARC), and CXCL12 (stromal derived factor 1,
SDF-1). I-309, which is produced in the skin affected with allergic
contact dermatitis to nickel, attracts ThIL-10 and Th2, but not Th1
cells, and may thus contribute to the regulation of the Th1-medi-
ated skin inflammation.
Materials and Methods
Culture medium and Abs
T lymphocytes were cultured in RPMI 1640 supplemented with 2 mM
glutamine, 1 mM sodium pyruvate, 1% nonessential amino acids, 0.05 mM
2-ME, 100 U/ml penicillin, and 100 g/ml streptomycin (all from Life
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Technologies, Chagrin Falls, OH) (complete RPMI) plus 10% heat-inac-
tivated FCS (HyClone Logan, UT) or 5% autologous plasma. The anti-
CD28 mAb (Leu-28, IgG1) was purchased from Becton Dickinson (San
Jose, Ca). Mouse mAbs anti-human CCR1 (53504.111, IgG2B), CCR2
(48607.121, IgG2B), CCR5 (45531.111, IgG2B), and CXCR3 (49801.111,
IgG1) were obtained from R&D Systems (Minneapolis, MN); anti-CCR3
(LS63 7B11, IgG2A) and anti-CCR4 (328B, IgG) mAbs were kindly pro-
vided by Leukosite (Cambridge, MA) and ICOS (Bothell, WA), respec-
tively; anti-CXCR1 (5A12, IgG2B), CXCR2 (6C6, IgG1) and CXCR4
(12G5, IgG2A) were purchased from PharMingen (San Diego, CA). Anti-
CD3 (UCHT-1, IgG1) was obtained from Immunotech (Marseille, France);
the FITC-conjugated anti-CLA mAb (HECA-452, rat IgM), the control
isotype FITC-conjugated rat IgM, and the control mouse IgG were pur-
chased from PharMingen. FITC-conjugated goat anti-mouse IgG were ob-
tained from Dako (Glostrup, Denmark).
T cell clones
T cell lines were derived from the blood and skin of nonatopic patients
affected by allergic contact dermatitis to nickel, as previously described
(12). Briefly, 95% pure CD4 T cells were negatively selected from the
nonadherent fraction of PBMC using immunomagnetic beads coated with
anti-CD19, anti-HLA-DR, and anti-CD8 mAbs (Dynal, Oslo, Norway).
Blood-derived CD4 T cells were expanded with autologous PBMC and
10 g/ml NiSO4 (Sigma-Aldrich, Milan, Italy) to enrich for nickel-specific
T cells. Skin-derived T cells were obtained from 4-mm punch biopsies
performed 48 h after the application of 5% NiSO4 in petrolatum on the
back of allergic patients. After extensive washing in PBS, biopsies were
placed in culture at 37°C with 5% CO2 in complete RPMI along with 5%
autologous plasma and 30 U/ml rhIL-2 (generously provided by Chiron
Italia, Milan, Italy). Medium was replaced every third day, and T cells
emigrating from the tissue were collected at day 10. Blood- and skin-
derived T cell lines were cloned by limiting dilution (0.5 cells/well) in the
presence of 2 105 PBMC, 30 U/ml IL-2, and 1% PHA in complete RPMI
plus 10% FCS. Clones were grown in the presence of IL-2 and periodically
stimulated with 1% PHA and feeder cells or plate-coated anti-CD3 (1 g/
ml) and soluble anti-CD28 (1 g/ml) mAbs. Ag specificity of T cell lines
and clones was tested using irradiated PBMC and 10 g/ml NiSO4 in
complete RPMI supplemented with 5% autologous plasma for 48 h and
pulsed with 5 Ci/ml [3H]TdR (Amersham, Little Chalfont, U.K.) for the
last 12 h of culture. Cultures were harvested onto fiber-coated 96-well
plates, and thymidine incorporation was measured in a beta counter (Top-
count; Packard, Groningen, The Netherlands). Supernatants from T cells
(106 cells/ml) stimulated in 24-well plates with immobilized anti-CD3 and
soluble anti-CD28 mAbs were collected after 48 h, filtered, and tested for
IL-10, IL-4, IFN- , and TGF- content by ELISA (R&D Systems).
RNase protection assay
Total RNA was extracted from resting and 6-to 48-h activated T cell clones
using TRIzol (Life Technologies) according to the manufacturer’s instruc-
tions. Two multiprobe template sets, hCR5 and hCR6 (RiboQuant; PharM-
ingen), were used for in vitro transcription reactions in the presence of a
GACU pool and a T7 RNA polymerase to synthesize [32P]UTP-labeled
antisense probes. RNase protection analysis of 2.5 g of total RNA was
performed after overnight hybridization at 60°C with 2.5 106 cpm of
hCR5 or hCR6, followed by digestion with RNase A and T1 according to
standard protocols. Protected fragments were treated with proteinase K,
extracted with phenol-chloroform plus isoamyl alcohol (50:1), and finally
precipitated in ethanol in the presence of ammonium acetate. The samples
were electrophoresed on 5% denaturing sequencing gels and then exposed
on film (Kodak, Rochester, NY). The levels of mRNA expression were
quantified by densitometric analysis with an imaging densitometer (model
GS-670; Bio-Rad, Hercules, CA), supported by the Molecular Analyst Im-
age software, and the values were normalized against the housekeeping
gene L32.
FACS analysis
ThIL-10 lymphocytes in resting condition or activated 48 h with immobi-
lized anti-CD3 were washed in PBS added with 1% FBS and stained with
specific mAb or isotype control Ig, followed by secondary anti-mouse
FITC-conjugated Ab. For CCR1 detection, cells were preincubated for 15
min with 2% paraformaldehyde and then permeabilized with 0.5% saponin
for 20 min before staining with the mAb or the isotype control. Cells were
analyzed with a FACScan equipped with CellQuest software (Becton
Dickinson).
Intracellular Ca2 concentration measurements
T cell clones were either left untreated or activated with anti-CD3 plus
anti-CD28 for 48 h in the presence of 30 U/ml IL-2. Thereafter, cells (5
106/ml) were washed and loaded with 8 M Fluo-3/acetoxymethyl ester in
the presence of 1 M pluronic F-127 (Molecular Probes, Eugene, OR) in
complete RPMI with 1% FBS for 40 min at 37°C with frequent gentle
agitation. Cells were then washed twice, stimulated with CCL3 (macro-
phage inflammatory protein (MIP)-1 , 200 ng/ml), MCP-1 (200 ng/ml),
CCL11 (eotaxin, 400 ng/ml), TARC (100 ng/ml), CCL4 (MIP-1 , 100
ng/ml), CCL19 (MIP-3 , 30 ng/ml), I-309 (200 ng/ml), CXCL8 (IL-8, 100
ng/ml), CXCL10 (IFN-induced protein of 10 kDa (IP-10), 100 ng/ml), and
SDF-1 (100 ng/ml) (all from R&D Systems), and finally analyzed on a
FACScan. Cells and chemokines were maintained at 37°C during the
assay.
Migration assay
Chemotactic property of each chemokine was evaluated measuring the
lymphocyte migration through a 5- m pore polycarbonate filter in 24-well
transwell chambers (Corning Costar, Cambridge MA) as previously de-
scribed (22). Briefly Th1, Th2, and ThIL-10 either in resting or stimulated
48 h with immobilized anti-CD3 plus anti-CD28 were added to the top
chamber suspended in complete RPMI plus 0.5% BSA at 1 106 cells/ml.
Various concentrations of the different chemokines were added to the bot-
tom chamber of the transwell (0.6 ml). After 1 h of incubation at 37°C with
5% CO2, cells transmigrated into the lower chamber were recovered and
counted with a FACScan for 60 s at a flow rate of 60 l/min, as previously
described (23). Results are shown as migration index, which represents the
ratio between T cells migrated to the lower chamber in the presence of the
agonistic chemokine and cells migrated in response to the medium alone.
RT-PCR analysis
Total cellular RNA was extracted from 4-mm punch skin biopsies obtained
at time 0 and 16, 48 and 60 h after the application of 5% NiSO4 on the back
of allergic individuals (n 2) using the acid guanidinium thiocyanate-
phenol-chloroform method. Total RNA (0.5–1 g) was reverse transcribed
using oligo(dT) primers and then subjected to amplification with a Gene-
Amp RNA PCR kit (Perkin-Elmer, Roche Molecular Systems, Branchburg,
NJ). The following synthetic oligonucleotides were used: for I-309, 5 -
ATG CAG ATC ATC ACC ACA GCC CTG and 3 -ACA GAA AAA
TGC TGA GGC ACT GCC (274-bp amplificate); for CCR8, 5 -CAT CAC
CCT CAT GAG TGT GG and 3 -CAC GTT GAA TGG GAC CCA GA
(410-bp amplificate); for IL-10, 5 -GAA GGA TCA GCT GGA CAA CTT
GTT G and 3 -GCT CCA AAT GTA GGG GCA GG (306-bp amplificate);
for IL-4, 5 -GCG ATA TCA CCT TAC AGG AG and 3 -TTG GCT TCC
TTC ACA GGA CA (308-bp amplificate); for IFN- , 5 -TGC AGG TCA
TTC AGA TGT AG and 3 -AGC CAT CAC TTG GAT GAG TT (306-bp
amplificate) (24). The -actin housekeeping gene was amplified with 5 -
TGA CGG GGT CAC CCA CAC TGT GCC CAT CTA and 3 -CTA GAA
GCA TTT GCG GTG GAC GAT GGA GGG primers (660-bp amplifi-
cate). To eliminate genomic DNA contamination, reverse transcription was
performed after digestion with RNase-free DNase (PharMingen) for 30
min at 37°C. As a control, reactions were also performed in the absence of
reverse transcriptase. For semiquantitative analysis, RNA concentrations,
primers, and PCR cycles were titrated to obtain standard curves to verify
linearity and to permit analysis of signal strength. The levels of mRNA
expression were quantified by densitometric analysis as described above,
with the values normalized against -actin.
Results
Chemokine receptor mRNA in resting and activated Th1, Th2,
and ThIL-10 nickel-specific T cells clones
T cell clones were isolated from either the peripheral blood or
lesional skin of patients affected with allergic contact dermatitis to
nickel. ThIL-10 clones released high amounts of IL-10, low levels
of IFN- , and very limited amounts or no IL-4, and expressed the
CLA receptor which allows the recruitment of memory T cells in
the skin (8) (Table I). To determine the chemokine receptor ex-
pression, T cell clones were collected in resting phase and 6–48 h
after anti-CD3/anti-CD28-induced activation, and the mRNA con-
tent was evaluated by RNase protection assay using CC and CXC
chemokine receptor multiprobe template sets. In resting condi-
tions, ThIL-10 cells expressed a wide range of CC and CXC recep-
tors (Figs. 1 and 2). As previously reported for other T cell subsets






















(25), TCR engagement strongly affected chemokine receptor ex-
pression. After a transient burst at 6 h in CCR1, CCR2, CCR4,
CCR5, and CCR8 mRNA, ThIL-10 clones down-regulated CXC
(CXCR1, CXCR3, and CXCR4) receptors, CCR2, and, to a lesser
extent, CCR3 and CCR8. In contrast, CCR1, CCR4, CCR5, and
CCR7 were up-regulated. When compared with Th1 and Th2,
ThIL-10 lymphocytes displayed a broader array of chemokine re-
ceptors, with significant expression of both the Th1-associated
CCR5 and CXCR3 and the Th2-associated CCR3, CCR4, and
CCR8 (13–18, 25). Interestingly, the mRNA signal for CCR8 was
FIGURE 1. CC and CXC chemokine receptor mRNA expressed by
nickel-specific ThIL-10, Th1, and Th2 clones. Receptor mRNAs were ex-
amined by RNase protection assay in resting T cell clones and 6–48 h after
stimulation with plate-bound anti-CD3 and soluble anti-CD28 in the pres-
ence of exogenous IL-2 (30 U/ml). Similar results were observed in four
ThIL-10, two Th1, and two Th2 clones.
FIGURE 2. Densitometric analysis of chemokine receptor mRNAs ex-
pressed by resting and activated T cell clones. Densitometric values were
calculated from RNase protection assay by laser densitometry and normal-
ized against the housekeeping gene L32. Results are expressed as the
mean SD of experiments performed on four ThIL-10, two Th1, and two
Th2 clones. Open columns, resting T cells; hatched columns, 6-h activated
T cells; and filled columns, 48-h activated T cells.











AR2.77 Skin 2.2 0.1 48.7 0.4 470 49 10 4,560 ThIL-10
AC5.53 Skin 1.9 0.2 22.1 3 195 980 0d 11,600 ThIL-10
CS1.12 Skin 0.9 0.03 11.9 0.8 247 440 10 4,390 ThIL-10
AR2.33 Blood 2.8 0.2 7.7 1.4 735 30 0 3,450 ThIL-10
AC5.52 Blood 0.6 0.05 7.4 1.1 210 300 0 1,650 ThIL-10
AR2.2 Skin 2 0.1 82.2 3.5 1067 0 11,930 1,670 Th2
AC6.14 Blood 2.1 0.4 32.2 0.7 189 140 21,700 4,890 Th2
CS1.19 Blood 0.5 0.02 19.8 0.2 342 28,420 140 50 Th1
AC5.41 Blood 1.9 0.3 41.6 3.1 561 2,780 250 85 Th1
a T cells (5 104 cells/well) were cocultured with irradiated PBMCs (105 cells/well) in the absence or presence of 10 g/ml NiSO4 for 3 days. Results are given as mean
cpm 103 SD of triplicate cultures.
b CLA expression was determined by flow cytometry analysis using the FITC-conjugated HECA-452 rat mAb. Data are expressed as MFI which represents the mean
fluorescence intensity of anti-CLA-stained cells subtracted from the fluorescence of FITC-labeled rat IgM.
c T cell clones were stimulated with immobilized anti-CD3 and soluble anti-CD28 mAbs (both at 1 g/ml) for 48 h, and supernatants were examined for cytokine content
by ELISA. Values are expressed as pg/ml/106 cells.
d Below the detection limits of the ELISA kit (pg/ml): IL-4, 4, IFN- , 3.
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2-fold stronger in resting ThIL-10 lymphocytes than in Th2 clones,
and the difference was even more pronounced upon activation,
being CCR8 markedly down-regulated in TCR-engaged Th2 lym-
phocytes, but only slightly in ThIL-10 cells. ThIL-10, but not Th1
and Th2, clones expressed low levels of CCR7 mRNA, which was
up-regulated upon activation. Finally, both resting and stimulated
ThIL-10 clones showed 1.5- to 3.5-fold higher CXCR4 mRNA lev-
els than Th1 and Th2 cells.
Chemokine receptor expression in resting and activated nickel-
specific ThIL-10 clones
FACS analysis confirmed the expression of the CCRs 1–5 and the
CXCRs 1, 3, and 4 on resting ThIL-10 lymphocytes, whereas
CXCR2 was negative (Fig. 3). Activated ThIL-10 lymphocytes
strongly reduced the surface expression of CCR1, CCR3, CCR5,
CXCR1, and CXCR3. Although CCR1 and CCR5 protein expres-
sion decreased, the corresponding mRNA signals were up-regu-
lated following TCR triggering. The expression of CCR2 and
CCR4, albeit reduced, was maintained at significant levels and that
of CXCR4 was unmodified after ThIL-10 activation.
Chemokine receptors signaling in resting and activated nickel-
specific ThIL-10 clones
To evaluate the functional relevance of chemokine receptor ex-
pression, we measured calcium mobilization in ThIL-10 lympho-
cytes after treatment with agonistic chemokines. Consistent with
the vast repertoire of receptors expressed, all of the chemokines
tested induced significant responses in resting ThIL-10 cells (Fig.
4). The most active chemokines were MCP-1 (CCR2 ligand),
I-309 (CCR8 ligand), MIP-1 (CCR1–CCR5 ligand), and MIP-1
(CCR5 ligand), followed by TARC (CCR4 ligand), IL-8 (CXCR1
ligand) and eotaxin (CCR3 ligand), SDF-1 (CXCR4 ligand), and
finally MIP-3 (CCR7 ligand). After activation, significant cal-
cium fluxes were measured in response to I-309, MCP-1, TARC,
and SDF-1, whereas the responses to the other chemokines were
strongly reduced or completely lost. Consistent with the up-regu-
lation of CCR7 mRNA, MIP-3 retained a slight stimulatory effect
on activated ThIL-10 clones. Notably, activated ThIL-10 cells be-
came unresponsive to MIP-1 and MIP-1 , in line with the de-
creased expression of CCR1 and CCR5 receptors. This finding has
been previously observed in mature dendritic cells and activated
monocytes (26, 27).
Chemotaxis of resting and activated nickel-specific Th1, Th2,
and ThIL-10 clones
The migratory behavior of Th1, Th2, and ThIL-10 lymphocytes was
compared by measuring their transmigration through transwell fil-
ters in response to different concentrations of agonistic chemokines
(Fig. 5). Resting ThIL-10 revealed an extraordinary capacity to mi-
grate in response to a broad array of chemotactic stimuli, including
both Th1- and Th2-associated chemokines. The highest migration
was achieved with MCP-1, MIP-1 , and MIP-1 , followed by
TARC, I-309, SDF-1, and eotaxin, whereas more limited re-
sponses were observed to IL-8, IP-10, and MIP-3 . ThIL-10 mi-
gration to MIP-1 , IP-10 (CCR5 and CXCR3 ligands), and to
eotaxin (CCR3 ligand) was lower compared with that of Th1 and
FIGURE 3. Chemokine receptors expressed by resting and activated
ThIL-10 lymphocytes. Cells in resting state (bold lines) or 48-h activated
with immobilized anti-CD3 (thin lines) were stained with the specific
mAbs or with the isotype control Ig (dashed lines), followed by FITC-
conjugated secondary Ab, and then examined with a FACScan. Results are
representative of four ThIL-10 clones.
FIGURE 4. Intracellular calcium fluxes induced in ThIL-10 clones by
chemokines. ThIL-10 cells were loaded with 8 M fluo-3/acetoxymethyl
ester in the presence of 1 M pluronic F-127 and tested for intracellular
calcium mobilization in response to different concentrations of agonistic
chemokines. Calcium fluxes were measured in the resting state and 48 h
after activation with anti-CD3/anti-CD28 in the presence of 30 U/ml IL-2.
Shown is one experiment of four performed with different ThIL-10 clones.
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Th2 clones, respectively. In contrast, I-309 induced a stronger mi-
gration in ThIL-10 than in Th2 cells. Responses to MIP-1 , MCP-1,
and TARC were comparable among the different Th cell subsets,
whereas ThIL-10 and Th2 migrated to a higher extent in response to
IL-8 compared with Th1 clones. IL-8 responsiveness was likely
due to CXCR1, but not CXCR2 triggering, since the latter receptor
was undetectable on ThIL-10 both at mRNA and protein levels.
Additionally, neutrophil-activating protein-2, a specific agonist of
CXCR2 but not CXCR1, failed to induce calcium mobilization and
migration of ThIL-10 (data not shown). Finally, only ThIL-10 cells
showed a slight migration to MIP-3 . After stimulation with anti-
CD3 and anti-CD28 mAbs, ThIL-10 cells markedly decreased their
migratory response to most of the chemokines, and, consistent
with the calcium fluxes, retained a significant migration to MCP-1,
I-309, TARC, and SDF-1. MCP-1 and TARC were also effective
in attracting activated Th1 and Th2 lymphocytes, whereas I-309
attracted Th2, but not Th1 cells. Activated Th1 lymphocytes main-
tained a significant response to MIP-1 , MIP-1 , and IP-10.
I-309, CCR8, and cytokine mRNA expression in allergic contact
dermatitis skin
Since I-309 appeared to selectively attract ThIL-10 and Th2 lym-
phocytes and was effective on both resting and activated ThIL-10
cells, its expression was investigated during allergic contact der-
matitis reaction, in combination with CCR8, IL-10, IL-4, and
IFN- . RT-PCR was performed on RNA extracted from unaffected
(time 0) skin and at 16, 48, and 60 h after nickel challenge. Fig. 6
demonstrates that I-309, CCR8, IL-10, and IL-4 mRNAs were un-
detectable in normal skin. Both CCR8 and I-309 were already
expressed at 16 h after nickel application and reached a peak at
48 h, whereas IL-4 and IL-10 mRNAs became detectable only
after 48 h. In contrast, a faint signal for IFN- mRNA was already
present in unaffected skin, augmented at 16– 48 h, and decreased
thereafter.
Discussion
We have analyzed the pattern of chemokine receptors and the mi-
gratory behavior of nickel-specific skin-homing IL-10-producing
FIGURE 5. Migratory response of ThIL-10 cells to chemokines. Migra-
tory responses to various concentrations of CC and CXC chemokines was
examined in resting ( ) and activated ( ) ThIL-10 cells. Data are expressed
as migration index (number of cells migrated with the agonistic chemo-
kine/number of cells migrated with medium alone; mean SD). Similar
results were obtained in three separate experiments using different ThIL-10
clones.
FIGURE 6. I-309, CCR8, and cytokine mRNA expression during aller-
gic contact dermatitis to nickel. A, RT-PCR analysis was performed on
RNA extracted from skin biopsies obtained from nickel-allergic patients at
time 0 and at 16–60 h after the application of 5% NiSO4 in petroleum. B,
Densitometric analysis was performed by normalizing the levels of RNA
against -actin. Similar results were obtained in biopsies from two patients.
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CD4 lymphocytes compared with polarized Th1 and Th2 cells.
Resting ThIL-10 regulatory cells coexpressed the Th1 (CXCR3 and
CCR5)- and Th2 (CCR3, CCR4, and CCR8)- associated receptors
as well as significant levels of CCR1, CCR2, CCR7, and CXCR4.
In vitro migration to TARC, MCP-1, and MIP-1 was similar in
all subsets. In contrast, resting ThIL-10 cells showed a lower re-
sponse to MIP-1 and IP-10 compared with Th1, and to eotaxin
compared with Th2 clones. Noteworthy, CCR8, considered a very
specific Th2 marker (17, 18), was highly expressed in ThIL-10 cells,
with I-309 attracting more efficiently ThIL-10 than Th2 cells. TCR-
engaged ThIL-10 lymphocytes down-regulated most chemokine re-
ceptors, both at the mRNA and protein levels. As a consequence,
activated ThIL-10 became unresponsive to many chemotactic stim-
uli, still maintaining a significant response to I-309, MCP-1,
TARC, and SDF-1. Interestingly, although CCR1 and CCR5
mRNA were up-regulated, FACS analysis revealed a strong down-
regulation of the receptors in activated ThIL-10, which became un-
responsive to MIP-1 and MIP-1 . This finding may indicate a
posttranscriptional regulation, as suggested to occur for CCR5 in
activated dendritic cells and monocytes (26, 27). CCR4, which has
been associated with Th2 polarization (15, 16, 18), was expressed
by all of the skin-homing T cell subsets, although at higher levels
in resting Th2 cells compared with Th1 and ThIL-10 lymphocytes
(10- and 2-fold higher, respectively). This finding is consistent
with the recent report by Campbell et al. (28), indicating that
CCR4 is involved in the skin homing of memory T lymphocytes,
being coexpressed on the majority of CLA T cells independently
of the cytokine profile.
IL-10-releasing T lymphocytes with regulatory function have
been obtained in vivo after repeated intranasal stimulation with
peptide Ag (29) or repeated superantigen challenge (30), and fol-
lowing immunization through UVB-irradiated skin (31). In addi-
tion, Groux et al. (32) have shown that murine and human lym-
phocytes cultured in the presence of IL-10 develop a phenotype
characterized by high release of IL-10, IL-5, and TGF- , variable
amounts of IFN- , and no IL-4. These lymphocytes, called T reg-
ulatory cells 1 (Tr1), inhibit immune responses both in vitro and in
vivo in a IL-10-dependent manner. More recently, a Tr1 polariza-
tion was induced in vitro by using dendritic cells treated with cor-
ticosteroids (33). Our skin-homing ThIL-10 cells resemble Tr1 lym-
phocytes, but release lower levels of IFN- and display variable
TGF- production. Moreover, nickel-specific ThIL-10 lymphocytes
display the IL-12R 2 chain, the CD26 and the lymphocyte acti-
vation Ag-3 (12), markers related to a Th1 polarization. Whether
these suppressive ThIL-10 cells represent a distinct Th subset or a
further maturation step of Th1 or Th2 cells has to be determined.
An interesting observation of our study was that I-309 was ca-
pable of attracting more efficiently ThIL-10 than Th2 cells, both in
resting and activated conditions, whereas it was ineffective on Th1.
We also found that I-309 mRNA was significantly expressed in the
skin after Ag challenge. I-309 expression paralleled that of CCR8
and preceded IL-4 and IL-10 expression. I-309-mediated recruit-
ment of ThIL-10 cells may thus represent an important mechanism
for terminating Th1-mediated allergic reactions and limiting ex-
cessive tissue damage. In line with this hypothesis, it has been
shown that administration of IL-10 strongly reduces murine con-
tact hypersensitivity (34, 35), and IL-10-deficient mice show en-
hanced and more sustained cutaneous inflammatory responses to
haptens (36). Activated Th1 and Th2 lymphocytes are the major
source of I-309 (25, 37), but we have recently found a significant
production of I-309 by IFN- -stimulated keratinocytes (C. Al-
banesi, C. Scarponi, S. Sebastiani, A. Cavani, M. Federici, S. Soz-
zani, and G. Girolomoni, manuscript in preparation), which may
therefore contribute relevantly to the recruitment of regulatory
ThIL-10 cells in the skin. In aggregate, our results demonstrate that
ThIL-10 display a broad array of functional chemokine receptors,
which allow their comigration along with Th1 and Th2 cells. The
expression of high levels of CCR8 in regulatory ThIL-10 lympho-
cytes may be advantageously exploited to control Th1-mediated
allergic disorders.
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